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Gastric cancer Mortality trends in 
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age, period and cohort patterns in 
Argentina and chile
Maria del pilar Diaz1, Gloria icaza2,3, Loreto nuñez3,4 & Sonia A. pou  1*
Although Argentina and Chile are neighboring countries, gastric cancer (GC) is the first cancer death 
cause in the Chilean male population, while it is ranked in fifth place for Argentinean males. This study is 
the first to identify the differential time-patterns associated with the age-period-cohort effects for the 
last few decades (1990–2015) in these Southern Cone countries. Trends of age-standardized truncated 
mortality rates (ASMR) for GC were analyzed using log-linear Poisson age-period-cohort models, 
including cubic splines for each component. The ASMR trends for GC decreased in both sexes but more 
considerably in Chile and more favorably for males (annual percentage changes 2002–2015 = −3.5, 
95%CI: −3.9 to −3.1). Moreover, GC age-specific mortality rates were noticeably higher in Chile. A 
favorable decreasing mortality risk throughout the periods (from 2000) and by cohort was observed for 
both countries; however, the risk reduction has stabilized in younger female cohorts since 1950-cohort. 
In conclusion, overall favorable decreasing trends for GC mortality were found; however, when age-
period-cohort effects were disentangled, Chile and younger female cohorts showed a more unfavorable 
scenario. Obesity, lifestyles, and environmental conditions (like altitude) may explain country 
differences. This analytical approach may be a valuable tool to be replicated in other countries with no 
population-based cancer registries and acceptable mortality data quality.
Gastric cancer (GC) is one of the five most frequent cancers (excluding non-melanoma skin cancer) in the 
world1,2 and the third leading cause of cancer death in both sexes worldwide1. Although GC mortality rates have 
been declining over the last few decades, the rates in several countries in South America and Asia remain the 
highest in the world3.
The number of deaths in Latin America and the Caribbean attributable to this cancer is among the high-
est in the world; South America is the third region with one of the highest age-standardized (World Standard 
Population) incidence rates for GC, preceded only by Eastern Asia and Central and Eastern Europe1. 
Characteristics of the Southern Cone that distinguish it from the northern area of South America include unu-
sually high consumption of meat, mainly barbecued, and wine consumption, which has already been reported 
as associated with cancer4. However, Chile and Argentina are among the countries in South America with the 
highest and lowest age-standardized mortality rates (ASMR) for both sexes, respectively (ranked in third and 23th 
place among the 32 countries in the region), with overall ASMR equals of 17.9 and 6.4 per 100,000 in men and 
women for Chile, and 7.5 and 3.0 for Argentina, respectively5. Thus, even though they are neighboring countries 
in the Southern Cone with similar reports of the human development index and behaviors, the health differences 
between these countries should be analyzed. Helicobacter pylori (H. pylori) infection is a primary risk factor of 
GC. It is estimated that about half of the world’s population is infected with this bacterium6, although GC occur-
rence cannot be explained by H. pylori infection alone. Damage to the mucosal barrier due to H. pylori-induced 
inflammation enhances the carcinogenic effect of other risk factors7. Substantial epidemiological evidence 
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strongly suggests that GC risk increases with high salt intakes and decreases with high intakes of fruit and vege-
tables8. Changes in alcohol consumption and tobacco smoking may also play a role8.
To date, several studies have analyzed GC mortality trends, splitting the temporal variations into the rec-
ognized time-components, such as age, cohort of birth, and period of death. Cohort effects may provide some 
evidence of early-stage carcinogens or risk factors that may influence GC mortality, and period effects may 
demonstrate the effects of screening and adjuvant treatment on GC mortality. No systematic epidemiological 
study has been conducted that describes recent and temporal trends in GC mortality in South American coun-
tries. In this paper, we explore GC mortality trend differences between Chile and Argentina in the 1990–2015 
period, identifying the time patterns associated with age, period, and birth cohort effects.
Methods
Mortality data was drawn from death certificates provided by the Ministry of Health for Chile and the National 
Health Ministry for Argentina, for the study period (1990–2015 for Chile and 1991–2015 for Argentina). GC 
deaths were classified by C16 (ICD-10) and 151 (ICD-9) codes.
Chilean population data from the 1990–2012 period was obtained from the 1992 and 2002 Census inter-
censal estimations, and from the 2013–2015 period from administrative data provided by the National Institute of 
Statistics (INE) and the Department of Statistics and Health Information (DEIS). Exponential interpolation from 
1991, 2001, and 2010 population census data reported by the National Statistics and Census Institute (INDEC) 
was used for data for Argentina. Truncated (30–79 years old) age-standardized (World Standard Population) 
mortality rates (ASMR, per 100,000 person-years) from GC were estimated by sex for all years for each country.
The datasets analyzed during the current study are available from the corresponding author on request.
compliance with ethical standards. The present study follows the ethical standards of the institu-
tional research committee and the 1964 Declaration of Helsinki and its later amendments. No ethical approval 
was required by our institutions as the research involved anonymized records and datasets available in the public 
domain. Specifically, the mortality databases used in this study do not contain any information that may identify the 
research subjects, and the data is available from the Health Statistics and Information Division for Argentina and 
Chile (called DEIS) upon reasonable request and with permission from the Ministries of Health from these countries 
(publicly available online at www.minsal.cl for Chile). Formal consent is not required for this type of study.
Statistical analysis. Joinpoint regression analysis9 was performed to achieve greater descriptive accuracy of 
overall temporal trends. Models were fitted to ASMR by sex and separately for each country, providing estimates 
of the annual percent change (AnPC) and its 95% Confidence Interval (95%CI). Joinpoint regression program, 
Version 4.6.0.0. (Statistical Research and Applications Branch, National Cancer Institute; 2018) was used.
By considering age, calendar period, and birth cohort, Age-Period-Cohort (APC) models incorporated his-
torical or continuous changes in these components. These models suffer from an identifiability problem 
(cohort = period–age); therefore, different approaches for fitting were suggested. We chose the Carstensen pro-
posal10, which deals with age, period, and cohort as continuous variables (not as “class variables” or factor) and 
uses appropriated spline functions to represent them. Thus, the general form of a multiplicative age-period model 
for rates, λ = + +a p f a g p h clog[ ( , )] ( ) ( ) ( ), where f a g p h c( ), ( ), ( ) are restricted cubic (natural) splines func-
tions for age, period, and cohort terms within a GLM (Generalized Linear Models) framework with a Poisson 
family error structure, a log link function, and an offset of log(person risk-time) as exposure were used. The 
model was adjusted for sex covariate, and country effect for the complete mortality dataset was also included. 
Fitting the country effect in a single model allowed the calculation of the time-dependent mortality rate ratio 
(MRR) for the countries by age. After fitting, the age effects were calculated as rates for the reference period in the 
age–period model, while the period (or cohort) effects were calculated as rate ratios (RR) relative to the reference 
period (or cohort). The best-fitting model was defined according to the Akaike information criterion (AIC). 
Rutherford Stata code11 was used for fitting all models in Stata 14.0.
Results
Joinpoint regression by country. Between 1990 and 2015, a total of 54,857 deaths from GC were regis-
tered in Chile and 54,540 in Argentina between 1991 and 2015. About 70% of these deaths were male and 30% 
female, in both countries. These percentages of deaths by sex were also observed in the first and last years of the 
study period. GC mortality rates in Chile, as well as in Argentina, revealed higher values for men than women 
between 30 and 79 years old (3:1 relationship in1990 and 2015), and the lowest rate was seen in 2015 (versus 1990, 
in both countries and sexes) (Table 1).
The ASMR of men and women for GC of both countries showed a decreasing trend. The main decrease was 
observed in males in Chile (from 2002, −3.5 AnPC; 95%CI: −3.9 to −3.1; p < 0.001). Nonetheless, a significant 
negative slope was also observed for Chilean females (1990–2015, −2.6 AnPC; 95%CI: −2.8 to −2.4; p < 0.001). 
In Argentina, the main descending slope was found in females for the 1990–2003 period (−2.1 AnPC; 95%CI: 
−2.6 to −1.6; p < 0.001). Likewise, a negative slope, with no breakpoint, was found in males (−2.0 AnPC; 95% 
CI: −2.2 to −1.9; p < 0.001) for the whole analysis period (Table 1).
Any tabulation of mortality data represents an information loss; thus, we decided to show period-cohort Crude 
Mortality Rates (CMR) to give an overview of rates and trends. Overall, the magnitudes of CMR were lower and 
more homogeneous for Argentina (Tables 2 and 3), over twice as high in males than in females mainly for Chile 
and for those belonging to birth cohorts up to 1933 (rates ranged from 102 to 303 in 100,000 males compared to 
31.3 to 118 in 100,000 females). For both countries, younger male and female birth cohorts showed lower rates 
even when increasing in age of death (column trend). Nearly parallel patterns followed each age group (diagonal 
trends) relative to the periods, and periods showed non-linear tendencies through dates of birth (row trends).
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Apc model by country. Significant effects by sex were obtained for each country-APC analysis (p < 0.001). 
When considering females as a reference, estimates of MRR were 2.89 (95% CI 2.83; 2.94) and 2.62 (95% CI 2.58; 
2.67) for Chile and Argentina, respectively. Age, cohort of birth, and period effects for Chile are shown in Fig. 1. 
APC models showed an estimated mortality rate ranging from less than 3.2 and 4.5 at age 30–39 for females and 
males, respectively, to about 116.6 and 276.7 at age 70 or older per 100,000 persons/years for females and males, 
respectively (Fig. 1). The age-effect curve showed a considerable increase in both sexes. Nonetheless, the notable 
overall decrease of birth-cohort effects patterns, in relation to the reference, were different between sexes, show-
ing that younger cohorts of women stave off that risk reduction. Similar period effects were estimated for both 
sexes, revealing increasing RR in the first part of the study period (before 2000) and then decreasing afterward.
Country Sex
Age-standardized mortality rate Tendency
1990 2015 Years AnPC (95% CI)
Argentina
Female 8.56 5.98 1991–20032003–2015
−2.1 (−2.6; −1.6)a
−0.8 (−1.3; −0.3) a
Male 24.77 15.48 1991–2015 −2.0 (−2.2; −1.9)a
Chile
Female 11.04 5.47 1990–2015 −2.6 (−2.8; −2.4)a
Male 28.48 14.96 1990–20022002–2015
−1.7 (−2.2; −1.2)a
−3.5 (−3.9; −3.1)a
Table 1. Tendency on age-standardized (World Standard Population) death rates per 100, 000 person from 
gastric cancer (truncated 30–79 years), between 1990 and 2015 in Argentina and Chile. AnPC, annual percent 
change; CI, confidence interval. aEstimated AnPC is significantly different from zero at the alpha 0.05 level.
Males Cohort
Period 1913 1918 1923 1928 1933 1938 1943 1948 1953 1958 1963 1968 1973 1978 1983
1991–1995 247.0 310.0 236.0 170.0 102.0 53.0 26.5 13.7 5.15 3.2 1.9
1996–2000 220.0 303.0 226.0 152.0 83.8 50.1 25.1 12.1 5.6 2.3 2.0
2001–2005 202.0 287.0 209.0 126.0 72.8 39.6 21.0 10.7 5.2 2.5 1.6
2006–2010 200.0 264.0 172.0 110.0 62.4 32.7 17.4 10.4 4.7 2.0 0.7
2011–2015 188.0 205.0 139.0 84.0 48.5 28.0 14.0 6.9 3.2 1.7 1.1
Females Cohort
Period 1913 1918 1923 1928 1933 1938 1943 1948 1953 1958 1963 1968 1973 1978 1983
1991–1995 99.2 118.0 83.3 54.3 31.3 18.9 9.3 5.8 3.2 2.2 1.3
1996–2000 71.8 111.0 80.1 45.8 25.7 14.0 8.4 4.4 3.2 1.5 1.7
2001–2005 72.9 101.0 67.4 38.3 21.7 13.3 7.7 5.3 3.1 1.9 1.8
2006–2010 72.3 83.8 53.9 34.1 20.0 11.2 7.1 4.4 2.7 1.7 1.2
2011–2015 60.6 74.9 44.7 30.2 16.2 9.7 6.1 4.8 2.9 1.5 1.2
Table 2. Specific mortality rates per 100,000 person-years of gastric cancer for period-cohort groups by sex in 
Chile during 1990–2015.
Males Cohort
Period 1913 1918 1923 1928 1933 1938 1943 1948 1953 1958 1963 1968 1973 1978 1983
1991–1995 108.0 100.0 75.2 53.9 36.2 21.0 12.2 7.01 3.4 1.7 1.1
1996–2000 91.5 95.6 70.2 51.7 32.4 19.7 11.4 6.5 3.4 1.6 0.8
2001–2005 81.6 83.3 66.9 44.3 29.7 19.2 10.7 5.9 2.8 1.2 1.1
2006–2010 77.7 77.9 52.1 38.9 27.4 16.1 9.9 5.4 2.8 1.1 0.5
2011–2015 68.6 68.9 50.2 34.9 21.3 14.1 8.6 4.5 2.5 1.2 1.0
Females Cohort
Period 1913 1918 1923 1928 1933 1938 1943 1948 1953 1958 1963 1968 1973 1978 1983
1991–1995 47.3 41.3 28.5 17.0 12.4 7.6 4.6 2.6 2.0 1.3 1.1
1996–2000 32.3 34.3 26.5 16.5 11.3 6.9 4.9 3.6 1.8 1.1 1.2
2001–2005 33.5 30.3 20.5 14.0 10.2 6.8 4.4 3.0 2.2 1.1 0.8
2006–2010 28.2 27.7 20.5 13.5 9.8 6.2 4.5 2.9 1.7 1.1 0.8
2011–2015 23.1 26.7 16.7 13.3 9.4 6.1 4.8 2.6 1.8 1.2 1.2
Table 3. Specific mortality rates per 100,000 person-years of gastric cancer for period-cohort groups by sex in 
Argentina during 1990–2015.
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For Argentina, different patterns for age, period, and cohort were observed for each sex (Fig. 2). The estimated 
mortality rate ranged from less than 2 to 5 at age 30–39 for females and males, respectively, to about 30.5 and 67.3 
at age 70 or older per 100,000 person-years for females and males, respectively (Fig. 2). While rates for women 
were substantially lower than those for men, for all ages, this pattern was not as remarkable as it was in Chile. The 
effect of the birth cohort had not decreased since 1950 for females; moreover, it became stationary and showed the 
adjacent region of the MRR profile includes one. The cohort effect for males was similar to that of Chilean males, 
although less pronounced. When increasing RR in the first decade of study, females showed a different outline for 
period effect related to males, in both countries.
All models (by sex and country) attained lower AIC values when eight degrees of freedom were selected, 
suggesting a better fitting model.
Joint APC model: country-effect assessment. Finally, the APC model fitting performed for the com-
plete dataset of mortality showed significant effects by country for both sexes (p < 0.001). Considering Argentina 
as the reference, MRR estimates were 7.08 (95%CI 6.95; 7.21) and 0.92 (95%CI 0.89; 0.94) for females and males, 
respectively. This result indicates that adjusted by time-components, GC mortality for females in Chile was 
noticeably higher than in Argentina, while an opposite effect was observed in males mainly for deaths occurring 
between 45 and 65 years old. Figure 3 illustrates time-dependent MRR for the age-by-country interaction and 
shows that the relationship between countries varies differently across age according to sex.
Discussion
The present analysis focused on the age-standardized and sex-specific mortality rates for GC in two countries, 
Chile and Argentina, in the American Southern Cone. Overall, the highest rates (age-, cohort- or period-specific 
rates) were observed in Chile, where the rate values were at least two-fold higher than in Argentina. Mortality 
trends decreased in both sexes between 1990 and 2015 and more substantially in Chile and more favorably for 
males. Through the APC analysis, the present study confirmed the direct effect by age, with an increasing ten-
dency in Chilean males; showed favorable decreasing mortality risk by cohorts in both countries; identifying 
that the younger female cohorts had a stabilized risk reduction since the 1950-cohort and similar increasing RR 
was found before 2000 and subsequent decreases for both countries. A main effect by country was obtained for 
both male and female populations. These findings confirm mortality differences between Chile and Argentina. 
GC represents 12.2% of all cancer deaths in Chile, while 4.7% in Argentina (2018)5. The number of cancer deaths 
is greatly influenced by the size and age composition of the population. In that sense, the APC model approach 
helps to understand the complex social, historical, and environmental factors that simultaneously impact individ-
uals and populations12, integrating changes in age, calendar period, and birth cohort components.
Age and period effects have been sufficiently explored in cancer research. The results of the APC model are 
useful for regional comparison. In this situation, the different risk factors prevalence among birth cohorts should 
be taken into account13. Cohort effects reflect the long-established generational effect of risk factors in early life, 
which manifest as a progressive increase or decrease in cancer risk within the population. Our work provides 
several focuses to explore possible exposure sources.
Figure 1. APC model fitting for gastric cancer data by sex (a: Females, b: Males) in Chile, 1990–2015 period. 
Age-related outcomes are expressed as specific-rates (from 30 to79 years old) per 100,000 person-years, 
and period of death, and cohort of birth effects interpreted as RR against the reference period (or reference 
cohort), which represents the median date of deaths between cases (or median date of birth among cases). 
For cohort effect, the reference categories were 1936.334 years for females (ASMR = 13.3) and 1935.334 for 
males (ASMR = 202.3), while 1995 and 2000 were those for the period effect in female and male populations, 
respectively. The leftmost solid line indicates the estimated age effect. Period of death and birth cohort effects 
are expressed in RR as solid lines (estimated effects, using reference indicated by a circle) on the right area of the 
graph, the longest of the solid lines show the estimated cohort effect, and the shortest line the estimated period 
effect. The regions adjacent to the lines provide the 95% confidence intervals.
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In the present study, similar cohort patterns were observed in Chile as well as in Argentina, which indicates 
that shared exposure risk factors in early life may be responsible. Some risk factors have been recognized as main 
determinants of GC, such as H. pylori infection, smoking, body fatness, alcohol and salt consumption, and other 
specific dietary habits (consumption of fruit, processed meat, grilled or barbecued meat, fish, and foods preserved 
by salting)8.
H. pylori infection has been recognized as the primary risk factor for GC14. Higher proportions of cancer cases 
attributable to infections are found in South America (35.4% in 2012)1, and some evidence reports an overall 
decline in the prevalence of H. pylori infection in Latin America15. In particular, a decreasing trend in H. pylori 
prevalence has been attributed to changes leading to a higher socioeconomic status, better hygiene practices, and 
less household overcrowding16, as has been the case in Chile and Argentina in the last decades. Although there is 
no data on temporal trends of H. pylori infection for the whole population of these countries, a study performed 
in Buenos Aires (the most populated city in Argentina) showed a significant decrease in H. pylori rates from 
2002 to 2009 in pediatric populations with gastrointestinal symptoms17. Also, Oporto et al.18 reported that in the 
Region de La Araucanía in Chile, one of the regions with the highest GC mortality rates in this country, H. pylori 
Figure 2. APC model fitting for gastric cancer data by sex (a: Females, b: Males) in Argentina, 1990–2015 
period. Age-related outcomes are expressed as specific-rates (from 30 to79 years old) per 100,000 person-years, 
and period of death and cohort of birth effects interpreted as RR against the reference period (or reference 
cohort), which represents the median date of deaths between cases (or median date of birth among cases). 
Cohort references were 1938 and 1935 for females and males (ASMR equal to 7.61 and 68.5, respectively), 
also using the same reference (year 2000) for both sexes for period effect. The leftmost solid line indicates the 
estimated age effect, the longest of the solid lines on the RR half of the graph refers to the estimated cohort 
effect, and the shortest line in the RR half of the graph represents the estimated period effect. The circle indicates 
the reference point, and the regions adjacent to the lines provide the 95% confidence intervals.
Figure 3. Graph of time-dependent MRR for the age-by-country interaction (a: Females, b: Males). Chile 
and Argentina, 1990–2015 period. The solid line is the MRR (Chile compared with Argentina) for the age-by-
country interaction three degrees of freedom for splines (from the model using reduced splines for age and 
cohort, having fitted a model with eight degrees of freedom for each of the components). The shaded region 
indicates the 95% confidence interval. The dashed line gives the MRR by country in terms of the age component 
from the model with the full interaction by country using 8 degrees of freedom for each component. The dotted 
lines form the appropriate 95% confidence interval.
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infection has decreased significantly, and Da Costa et al.19 observed a 16% reduction in prevalence in patients at 
the University of Chile’s Clinical Hospital over 11 years. Thus, the decrease observed in mortality trends (from 
cohort effect) could be explained, in part, by the reduction in H. Pylori prevalence.
Nonetheless, our findings reveal remarkably higher GC mortality rates by cohort group in Chile than in 
Argentina. It is noticeable that Chile still has a high prevalence of H. pylori, about 73% in adults15, like the preva-
lence found in some Asian countries20. In contrast, Argentina has around 36% in adults21. Besides, some studies 
have reported an increased risk of GC among populations who reside at high altitudes (as a surrogate for factors 
that might cluster in mountainous regions such as host genetics, bacterial, dietary, and environmental varia-
bles)22,23. Interestingly, the mean altitude of Santiago de Chile (the most populated city in Chile) is around 570 m 
above sea level, while for Buenos Aires (Argentina), the mean is 25 m.
Furthermore, differences observed in GC mortality rates (by age, period or cohort group) between Chile 
and Argentina could be related to the higher obesity prevalence in Chile (around 31.2% vs. 18% in Argentina, 
according to national surveys), a higher consumption of some foods with recognized promoting effects on GC 
occurrence (such as fish preserved by salting, broiled or charbroiled, and alcoholic beverages), and a lower citrus 
fruit intake (dietary protective factor for GC reported by the literature)8.
Beyond that, our findings show that Chile and Argentina follow a decreasing global tendency of GC mortality 
linked to the cohort effect; some differences between sexes should be highlighted. In Argentina according to the 
National Surveys of Risk Factors for chronic diseases, the prevalence of tobacco consumption in adults decreased 
from 29.7% in 2005 to 25.1% in 2013, being more prevalent in men (35.1% and 29.9% in 2005 and 2013, respec-
tively) than in women (24.9% and 20.9%, respectively). This higher male prevalence in tobacco consumption was 
also highlighted in the 2012 Global Adult Tobacco Survey report in Chile. The stagnation of the cohort downward 
effect in women in both countries, a decade after it was reported in Europe24, maybe because women adopted 
smoking habits later compared to men and the decreasing age of onset of tobacco consumption in women25.
Period effects mostly reflect changes in the classification of diseases and advancements in diagnosis tech-
niques or treatment26. Overall, the patterns of period rate ratio appear to be similar in Chile and Argentina, 
with an upward trend until around 2000, decreasing thereafter, which might be attributable to improvements in 
treatments and screening services. It has been suggested that GC survival rates are higher when there are early 
detection and diagnosis8. In Chile, some authors highlight the experience gained during the last decade by medi-
cal teams specialized in GC both for diagnosis and management of post-surgery adverse events27. Given that GC 
is ranked as the first cancer death cause (ranked by ASMR)5 among males in Chile, higher priority in the public 
health agenda was given for this country. Currently, Chile has two population-based interventions for GC treat-
ment and H. Pylori treatment for symptomatic patients that were implemented in 2006 and 2013, respectively28. 
This scenario, in terms of public health, maybe a factor that contributes to explaining the rapid higher decreasing 
trend in males in this country, compared with Argentina, where focused strategies against this cancer type have 
not been defined.
As GC is a long-latent period disease, aging is a major risk factor influencing trends; in fact, GC is frequent in 
adults over the age of 508. Consistently, in the present work, GC mortality rates increased exponentially with age, 
both by sex and country. From the APC approach, age effects reflect the biological and social processes of aging.
To our knowledge, there are no comparative studies between countries using the APC approach for cancer 
mortality in South America. Our work is the first to explore time-component effects in a joined analysis which 
can identify country-effect. One of the strengths of the present work is the use of natural cubic splines to over-
come the known-called identifiability problem from the classical APC approach and to represent age, period, and 
cohort effects into a generalized linear model approach. Natural cubic splines are favored over step-functions, 
because they are flexible, and reflect smooth changes over time, which allow a more biologically plausible way of 
modeling non-communicable disease data29. However, it is useful to consider some methodological issues for the 
interpretation of cohort effects. A weakness of this work is that the study periods of the two countries analyzed 
were not completely matched, although this only occurred at the beginning of the time period (time-series start-
ing in 1990 for Chile and 1991 for Argentina). Besides, it should be highlighted that the APC model has a system-
atic tendency to favor cohort effects as they have higher weight and a larger number of parameters; furthermore, 
changes in trends in recent cohorts should be interpreted with caution since the earlier and more recent cohorts 
are based on smaller numbers of deaths24.
From an epidemiological viewpoint, a risk factor perspective is more closely related to incidence than mor-
tality trends. However, due to the absence of national cancer registers and the acceptable quality of mortality 
statistics in both countries (civil registration coverage of cause-of-death above 90%)30, mortality rates seem to be 
the most reliable option in Latin American cancer epidemiology research. An additional limitation was that the 
GC analysis was performed without distinguishing subtypes (cardiac and non-cardiac) when specific etiological 
pathways are recognized for each one. Concluding, our findings showed an overall favorable decreasing trend for 
GC mortality risk in the 1990–2015 period for Argentina and Chile. However, we emphasize that GC remains 
a significant health problem in the Southern Cone region, especially for Chile, where the burden of mortality 
(measured by age-, cohort-, and period-specific rates) was noticeably high. Several underlying factors that could 
explain similarities and differences between countries were pointed out and discussed by using the APC perspec-
tive; nonetheless, the stagnation of the cohort effect in women should be further evaluated. Thus, increased efforts 
focused on the high-risk population are needed in Chile, including cost-effective population-based interventions, 
such as H. pylori and endoscopic screening, for GC prevention and treatment, respectively31. At the same time, in 
both countries, public health interventions aimed at reducing the prevalence of potentially modifiable risk factors 
(such as tobacco use, unhealthy dietary intake, and alcohol consumption) should be maintained and strengthened 
over time32, considering gender imbalance when these interventions are targeting GC burden reduction. Finally, 
we highlight that the present analytical approach may be a valuable tool to be replicated in other countries with 
no population-based cancer registries and acceptable mortality data.
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Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on 
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